What Is Wegovy? The Complete UK Guide
If you’re exploring weight loss options, you may have heard of Wegovy. In this guide, we explain everything you need to know about this powerful prescription treatment – from how it works to its proven clinical benefits.
Medical Disclaimer: Wegovy is a prescription-only medicine in the UK. You must speak with a qualified healthcare provider to determine clinical suitability. It should always be used alongside a reduced-calorie diet and increased physical activity.
Understanding the Medication
Doctors prescribe Wegovy® to help adults and adolescents manage their weight. It contains semaglutide, a substance that mimics a naturally occurring hormone (GLP-1) in your body to help regulate appetite and food intake.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has also approved Wegovy®—unlike many other weight loss medications—to reduce the risk of serious heart problems in people who are overweight or obese and already living with cardiovascular disease. You can learn more about this in our dedicated Wegovy and heart disease guide.
How Does Wegovy Work?
Wegovy works by targeting areas of the brain that control hunger and fullness. As a result, it helps you feel fuller for longer, making it easier to eat less and maintain a caloric deficit. Because it is injected just once weekly, it fits easily into most people’s routines.
Proven Clinical Benefits
Wegovy offers multiple health benefits, backed by the extensive SELECT and STEP clinical trial programmes testing more than 13,000 people.
In the major STEP 1 clinical trial, patients using Wegovy lost an average of 15–17% of their body weight over 68 weeks, compared to just 2.4% in the placebo group. Many users report better mobility and reduced joint pain.
In the SELECT trial, patients with existing heart disease and a BMI of 27 or higher had a 20% lower risk of heart attack, stroke, or death from cardiovascular causes when using Wegovy.
The cardiovascular benefits observed in trials were seen on top of standard heart treatments, meaning it provides additional protection alongside standard cholesterol and blood pressure medications.
Adolescents aged 12 and older can use it. However, clinical guidelines state that if a teen doesn’t lose at least 5% of their BMI after 12 weeks on the maximum dose, doctors may recommend stopping treatment.
Who Should Use Wegovy?
Because Wegovy is a prescription-only medicine, a healthcare provider must assess you. You may be eligible for treatment in the UK if you meet one of the following criteria:
Adults with Obesity
You are an adult with a BMI of 30 or more (medically classified as obesity).
Weight-Related Conditions
You have a BMI between 27 and 30 alongside at least one weight-related condition, such as high blood pressure or cholesterol.
Adolescents (12+)
You are a teenager aged 12 or older, diagnosed with obesity, and weigh more than 60 kg.
Pharmacy Safety: If you are eligible for a prescription, always ensure you use a regulated pharmacy registered with the General Pharmaceutical Council (GPhC). We strictly audit providers before featuring them—read about the Monj Verified safety process.
Final Thoughts
If you’ve struggled to lose weight through diet and exercise alone, Wegovy is more than just a weight loss injection – it’s a clinically proven tool for improving overall health. With consistent use, lifestyle changes, and medical guidance, it may deliver benefits that go far beyond the number on the scale. To ensure transparency when starting your journey, you can review exactly how iGovy checks prices across verified UK pharmacies.
